Company Search:
Advanced Search
Sponsored Links
Ikena Oncology Inc Company Snapshot
Ikena Oncology Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ikena Oncology Inc with three other companies in this sector in UNITED STATES : Reata Pharmaceuticals Inc (2020 sales of $9.02 million of which 100% was Pharmaceutical), Alpine Immune Sciences Inc ($9.34 million of which 100% was Protein-based immunotherapies), and Spero Therapeutics Inc ($9.33 million of which 100% was Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Ikena Oncology Inc
  Stock Performance Chart for Ikena Oncology Inc
  Stock Data: Recent Stock Performance:
  Current Price (4/30/2021): 24.47
(Figures in U.S. Dollars)
1 Week 16.9%   13 Weeks -5.9%  
4 Weeks n/a   52 Weeks n/a  
Ikena Oncology Inc Key Data:
  Ticker: IKNA Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 9,194,000
(Year Ending Jan 2021).
Employees: 29
  Currency: U.S. Dollars Market Cap: 846,367,650
  Fiscal Yr Ends: December Shares Outstanding: 34,587,971
  Share Type: Common Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.